{"id":314,"date":"2017-11-01T10:20:01","date_gmt":"2017-11-01T02:20:01","guid":{"rendered":"http:\/\/web.csh.org.tw\/web\/224020\/?page_id=314"},"modified":"2017-11-01T10:20:01","modified_gmt":"2017-11-01T02:20:01","slug":"c%e5%9e%8b%e8%82%9d%e7%82%8e%e5%85%a8%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90%e8%97%a5%e7%89%a9%e7%b5%a6%e4%bb%98%e6%a2%9d%e4%bb%b6","status":"publish","type":"page","link":"https:\/\/web.csh.org.tw\/web\/224020\/?page_id=314","title":{"rendered":"C\u578b\u809d\u708e\u5168\u53e3\u670d\u5c0f\u5206\u5b50\u85e5\u7269\u7d66\u4ed8\u689d\u4ef6"},"content":{"rendered":"<p>10.7.5.Daclatasvir\uff08\u5982Daklinza\uff09\u53caasunaprevir\uff08\u5982Sunvepra\uff09(106\/1\/24\u3001106\/5\/15\uff09\uff1a<br \/>\n1.\u9650\u7528\u65bc\u53c3\u52a0\u300c\u5168\u6c11\u5065\u5eb7\u4fdd\u96aa\u52a0\u5f37\u6162\u6027\uff22\u578b\u53caC\u578b\u809d\u708e\u6cbb\u7642\u8a08\u756b\u300d\u4e4b\u6210\u4eba\u6162\u6027\u75c5\u6bd2\u6027C\u578b\u809d\u708e\u60a3\u8005\u3002<br \/>\n2.Daclatasvir\u8207asunaprevir\u5408\u4f75\u4f7f\u7528\u65bcAnti-HCV\u967d\u6027\u8d85\u904e\u516d\u500b\u6708\u3001HCV RNA\u70ba\u967d\u6027\u3001\u7121\u809d\u529f\u80fd\u4ee3\u511f\u4e0d\u5168\u4e4b\u75c5\u6bd2\u57fa\u56e0\u578b\u7b2c1b\u578b\u6210\u4eba\u75c5\u60a3\uff0c\u4e14\u9700\u7b26\u5408\u4e0b\u5217\u689d\u4ef6\uff1a(106\/5\/15\uff09<br \/>\n\u7d93\u7531\u809d\u7d44\u7e54\u5207\u7247\u6216\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cf\u6216Fibrosis-4 (FIB-4)\u8b49\u5be6\uff0c\u7b49\u540cMETAVIR system\u7e96\u7dad\u5316\u5927\u65bc\u6216\u7b49\u65bcF3\uff1b\u6216\u8d85\u97f3\u6ce2\u8a3a\u65b7\u70ba\u809d\u786c\u5316\u4f75\u98df\u9053\u6216\u80c3\u975c\u8108\u66f2\u5f35\uff0c\u6216\u8d85\u97f3\u6ce2\u8a3a\u65b7\u70ba\u809d\u786c\u5316\u4f75\u813e\u816b\u5927\u3002<br \/>\n\u8a3b\uff1a\u4ee5\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cf\u6216Fibrosis-4 (FIB-4)\u8b49\u5be6\u7b49\u540cMETAVIR system\u7e96\u7dad\u5316\u5927\u65bc\u6216\u7b49\u65bcF3\u4e4b\u5b9a\u7fa9\u70ba\uff1a<br \/>\n\u2160.\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cftransient elastography (Fibroscan)\u22679.5Kpa\u6216Acoustic Radiation Force Impulse elastography (ARFI)\u22671.81m\/sec\u3002<br \/>\n\u2161.Fibrosis-4 (FIB-4)\u22673.25\uff0c\u8a08\u7b97\u516c\u5f0f\u70ba[Age(years) \u00d7 AST(U\/L)] \/ [Platelet count(109\/L) \u00d7 \u221aALT(U\/L)]\u3002<br \/>\n3.\u4f7f\u7528\u524d\u61c9\u6aa2\u6e2c\u8840\u6db2\u75c5\u6bd2\u975e\u7d50\u69cb\u6027\u86cb\u767d5A\u8655(NS5A)\u4e0d\u5177\u6297\u85e5\u6027\u75c5\u6bd2\u682a\u8005\u65b9\u53ef\u4f7f\u7528\u3002<br \/>\n4.\u6bcf\u4eba\u7d66\u4ed8\u7642\u7a0b24\u9031\uff0c\u91ab\u5e2b\u6bcf\u6b21\u958b\u85e5\u4ee54\u9031\u70ba\u9650\u3002\u670d\u85e5\u5f8c\u9700\u5b9a\u671f\u76e3\u6e2c\u75c5\u6bd2\u91cf\uff0c\u4f7f\u75284\u9031\u5f8c\u75c5\u6bd2\u91cf\u672a\u80fd\u4e0b\u964d\u8d85\u904e\u4e8c\u500b\u5c0d\u6578\u503c(\u5373\u4e0b\u964d\u672a\u9054100\u500d)\u8005\uff0c\u61c9\u505c\u6b62\u6cbb\u7642\uff0c\u7d66\u4ed8\u4e0d\u8d85\u904e6\u9031\u3002<br \/>\n5.\u9650\u672a\u66fe\u7533\u8acb\u7d66\u4ed8\u5176\u4ed6\u540c\u985e\u5168\u53e3\u670d\u76f4\u63a5\u6297\u75c5\u6bd2\u85e5\u7269(direct-acting anti-viral, DAAs)\uff0c\u4e14\u4e0d\u5f97\u4f75\u7528\u5176\u4ed6DAAs\u3002<br \/>\n10.7.6.Ombitasvir\/paritaprevir\/ ritonavir\uff08\u5982Viekirax\uff09\u53cadasabuvir (\u5982Exviera) (106\/1\/24\u3001106\/5\/15\uff09\uff1a<br \/>\n1.\u9650\u7528\u65bc\u53c3\u52a0\u300c\u5168\u6c11\u5065\u5eb7\u4fdd\u96aa\u52a0\u5f37\u6162\u6027\uff22\u578b\u53caC\u578b\u809d\u708e\u6cbb\u7642\u8a08\u756b\u300d\u4e4b\u6210\u4eba\u6162\u6027\u75c5\u6bd2\u6027C\u578b\u809d\u708e\u60a3\u8005\u3002<br \/>\n2.Ombitasvir\/paritaprevir\/ ritonavir\u8207dasabuvir\u5408\u4f75\u4f7f\u7528\u65bcAnti-HCV\u967d\u6027\u8d85\u904e\u516d\u500b\u6708\u3001HCV RNA\u70ba\u967d\u6027\u3001\u7121\u809d\u529f\u80fd\u4ee3\u511f\u4e0d\u5168\u4e4b\u75c5\u6bd2\u57fa\u56e0\u578b\u7b2c1\u578b\u6210\u4eba\u75c5\u60a3\uff0c\u4e14\u9700\u7b26\u5408\u4e0b\u5217\u689d\u4ef6\uff1a(106\/5\/15)<br \/>\n\u7d93\u7531\u809d\u7d44\u7e54\u5207\u7247\u6216\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cf\u6216FIB-4\u8b49\u5be6\uff0c\u7b49\u540cMETAVIR system\u7e96\u7dad\u5316\u5927\u65bc\u6216\u7b49\u65bcF3\uff1b\u6216\u8d85\u97f3\u6ce2\u8a3a\u65b7\u70ba\u809d\u786c\u5316\u4f75\u98df\u9053\u6216\u80c3\u975c\u8108\u66f2\u5f35\uff0c\u6216\u8d85\u97f3\u6ce2\u8a3a\u65b7\u70ba\u809d\u786c\u5316\u4f75\u813e\u816b\u5927\u3002<br \/>\n\u8a3b\uff1a\u4ee5\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cf\u6216Fibrosis-4 (FIB-4)\u8b49\u5be6\u7b49\u540cMETAVIR system\u7e96\u7dad\u5316\u5927\u65bc\u6216\u7b49\u65bcF3\u4e4b\u5b9a\u7fa9\u70ba\uff1a<br \/>\n\u2160.\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cftransient elastography (Fibroscan)\u22679.5Kpa\u6216Acoustic Radiation Force Impulse elastography (ARFI)\u22671.81m\/sec\u3002<br \/>\n\u2161.Fibrosis-4 (FIB-4)\u22673.25\uff0c\u8a08\u7b97\u516c\u5f0f\u70ba[Age(years) \u00d7 AST(U\/L)] \/ [Platelet count(109\/L) \u00d7 \u221aALT(U\/L)]\u3002<br \/>\n3.\u7d66\u4ed8\u7642\u7a0b\u5982\u4e0b\uff0c\u91ab\u5e2b\u6bcf\u6b21\u958b\u85e5\u4ee54\u9031\u70ba\u9650\u3002\u670d\u85e5\u5f8c\u9700\u5b9a\u671f\u76e3\u6e2c\u75c5\u6bd2\u91cf\uff0c\u4f7f\u75284\u9031\u5f8c\u75c5\u6bd2\u91cf\u672a\u80fd\u4e0b\u964d\u8d85\u904e\u4e8c\u500b\u5c0d\u6578\u503c(\u5373\u4e0b\u964d\u672a\u9054100\u500d)\u8005\uff0c\u61c9\u505c\u6b62\u6cbb\u7642\uff0c\u7d66\u4ed8\u4e0d\u8d85\u904e6\u9031\u3002<br \/>\n(1)\u57fa\u56e0\u578b1a\u578b\u4e14\u7121\u809d\u786c\u5316\u8005\uff0c\u9700\u5408\u4f75ribavirin\u6cbb\u7642\uff0c\u7d66\u4ed812\u9031\u3002<br \/>\n(2)\u57fa\u56e0\u578b1a\u578b\u4e14\u5177\u4ee3\u511f\u6027\u809d\u786c\u5316(Child-Pugh score A)\u8005\uff0c\u9700\u5408\u4f75ribavirin\u6cbb\u7642\uff0c\u7d66\u4ed824\u9031\u3002<br \/>\n(3)\u57fa\u56e0\u578b1b\u578b\u4e14\u7121\u809d\u786c\u5316\u8005\u6216\u5177\u4ee3\u511f\u6027\u809d\u786c\u5316(Child-Pugh score A)\u8005\uff0c\u7d66\u4ed812\u9031\u3002<br \/>\n4.\u9650\u672a\u66fe\u7533\u8acb\u7d66\u4ed8\u5176\u4ed6\u540c\u985e\u5168\u53e3\u670d\u76f4\u63a5\u6297\u75c5\u6bd2\u85e5\u7269(direct-acting anti-viral, DAAs)\uff0c\u4e14\u4e0d\u5f97\u4f75\u7528\u5176\u4ed6DAAs\u3002<br \/>\n10.7.7.Elbasvir\/grazoprevir\uff08\u5982Zepatier\uff09(106\/8\/1\uff09\uff1a<br \/>\n1.\u9650\u7528\u65bc\u53c3\u52a0\u300c\u5168\u6c11\u5065\u5eb7\u4fdd\u96aa\u52a0\u5f37\u6162\u6027\uff22\u578b\u53caC\u578b\u809d\u708e\u6cbb\u7642\u8a08\u756b\u300d\u4e4b\u6210\u4eba\u6162\u6027\u75c5\u6bd2\u6027C\u578b\u809d\u708e\u60a3\u8005\u3002<br \/>\n2.\u9650\u4f7f\u7528\u65bcAnti-HCV\u967d\u6027\u8d85\u904e\u516d\u500b\u6708\u3001HCV RNA\u70ba\u967d\u6027\u3001\u7121\u809d\u529f\u80fd\u4ee3\u511f\u4e0d\u5168\u4e4b\u75c5\u6bd2\u57fa\u56e0\u578b\u7b2c1\u578b\u6216\u7b2c4\u578b\u6210\u4eba\u75c5\u60a3\uff0c\u4e14\u9700\u7b26\u5408\u4e0b\u5217\u689d\u4ef6\uff1a<br \/>\n\u7d93\u7531\u809d\u7d44\u7e54\u5207\u7247\u6216\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cf\u6216FIB-4\u8b49\u5be6\uff0c\u7b49\u540cMETAVIR system\u7e96\u7dad\u5316\u5927\u65bc\u6216\u7b49\u65bcF3\uff1b\u6216\u8d85\u97f3\u6ce2\u8a3a\u65b7\u70ba\u809d\u786c\u5316\u4f75\u98df\u9053\u6216\u80c3\u975c\u8108\u66f2\u5f35\uff0c\u6216\u8d85\u97f3\u6ce2\u8a3a\u65b7\u70ba\u809d\u786c\u5316\u4f75\u813e\u816b\u5927\u3002<br \/>\n\u8a3b\uff1a\u4ee5\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cf\u6216Fibrosis-4 (FIB-4)\u8b49\u5be6\u7b49\u540cMETAVIR system\u7e96\u7dad\u5316\u5927\u65bc\u6216\u7b49\u65bcF3\u4e4b\u5b9a\u7fa9\u70ba\uff1a<br \/>\n\u2160.\u809d\u81df\u7e96\u7dad\u5316\u6383\u63cftransient elastography (Fibroscan)\u22679.5Kpa\u6216Acoustic Radiation Force Impulse elastography (ARFI)\u22671.81m\/sec\u3002<br \/>\n\u2161.Fibrosis-4 (FIB-4)\u22673.25\uff0c\u8a08\u7b97\u516c\u5f0f\u70ba[Age(years) \u00d7 AST(U\/L)] \/ [Platelet count(109\/L) \u00d7 \u221aALT(U\/L)]\u3002<br \/>\n3.\u7d66\u4ed8\u7642\u7a0b\u5982\u4e0b\uff0c\u91ab\u5e2b\u6bcf\u6b21\u958b\u85e5\u4ee54\u9031\u70ba\u9650\u3002\u670d\u85e5\u5f8c\u9700\u5b9a\u671f\u76e3\u6e2c\u75c5\u6bd2\u91cf\uff0c\u4f7f\u75284\u9031\u5f8c\u75c5\u6bd2\u91cf\u672a\u80fd\u4e0b\u964d\u8d85\u904e\u4e8c\u500b\u5c0d\u6578\u503c(\u5373\u4e0b\u964d\u672a\u9054100\u500d)\u8005\uff0c\u61c9\u505c\u6b62\u6cbb\u7642\uff0c\u7d66\u4ed8\u4e0d\u8d85\u904e6\u9031\u3002<br \/>\n(1)\u57fa\u56e0\u578b\u7b2c1a\u578b\u4e14\u6cbb\u7642\u524d\u672a\u5e36\u6709NS5A\u6297\u85e5\u6027\u76f8\u95dc\u591a\u5f62\u6027\u75c5\u6bd2\u682a\uff1a<br \/>\n\u2160.\u7d66\u4ed812\u9031\u3002<br \/>\n\u2161.\u82e5\u70ba\u5148\u524d\u4f7f\u7528interferon\/ ribavirin\/\u86cb\u767d\u9176\u6291\u5236\u5291(protease inhibitor)\u5408\u4f75\u6cbb\u7642\u5931\u6557\u8005\uff0c\u9700\u5408\u4f75ribavirin\u6cbb\u7642\uff0c\u7d66\u4ed812\u9031\u3002<br \/>\n(2)\u57fa\u56e0\u578b\u7b2c1a\u578b\u4e14\u6cbb\u7642\u524d\u5e36\u6709NS5A\u6297\u85e5\u6027\u76f8\u95dc\u591a\u5f62\u6027\u75c5\u6bd2\u682a\uff0c\u9700\u5408\u4f75ribavirin\u6cbb\u7642\uff0c\u7d66\u4ed816\u9031\u3002<br \/>\n(3)\u57fa\u56e0\u578b\u7b2c1b\u578b\uff1a<br \/>\n\u2160.\u7d66\u4ed812\u9031\u3002<br \/>\n\u2161.\u82e5\u70ba\u5148\u524d\u4f7f\u7528interferon\/ ribavirin\/\u86cb\u767d\u9176\u6291\u5236\u5291\u5408\u4f75\u6cbb\u7642\u5931\u6557\u8005\uff0c\u9700\u5408\u4f75ribavirin\u6cbb\u7642\uff0c\u7d66\u4ed812\u9031\u3002<br \/>\n(4)\u57fa\u56e0\u578b\u7b2c4\u578b\uff1a<br \/>\n\u2160.\u7d66\u4ed812\u9031\u3002<br \/>\n\u2161.\u82e5\u70ba\u5148\u524d\u4f7f\u7528interferon\/ ribavirin\u5408\u4f75\u6cbb\u7642\u4e2d\u767c\u751f\u75c5\u6bd2\u5b78\u5931\u6557\u8005\uff0c\u9700\u5408\u4f75ribavirin\u6cbb\u7642\uff0c\u7d66\u4ed816\u9031\u3002<br \/>\n4.\u9650\u672a\u66fe\u7533\u8acb\u7d66\u4ed8\u5176\u4ed6\u540c\u985e\u5168\u53e3\u670d\u76f4\u63a5\u6297\u75c5\u6bd2\u85e5\u7269(direct-acting anti-viral, DAAs)\uff0c\u4e14\u4e0d\u5f97\u4f75\u7528\u5176\u4ed6DAAs\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>10.7.5.Daclatasvir\uff08\u5982Daklinza\uff09\u53caasunaprevi &hellip; <a href=\"https:\/\/web.csh.org.tw\/web\/224020\/?page_id=314\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":52,"menu_order":7,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-314","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=\/wp\/v2\/pages\/314"}],"collection":[{"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=314"}],"version-history":[{"count":1,"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=\/wp\/v2\/pages\/314\/revisions"}],"predecessor-version":[{"id":315,"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=\/wp\/v2\/pages\/314\/revisions\/315"}],"up":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=\/wp\/v2\/pages\/52"}],"wp:attachment":[{"href":"https:\/\/web.csh.org.tw\/web\/224020\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}